The Green Journal
Audio Summaries

Association of Respiratory Syncytial Virus Vaccination During Pregnancy With Adverse Obstetric and Neonatal Outcomes

Jun 18, 2026

The authors aimed to evaluate the safety of the bivalent prefusion F subunit-based respiratory syncytial virus vaccine (RSVpreF) during pregnancy, specifically assessing its association with adverse obstetric and neonatal outcomes. Their findings indicate that while there was no significant increase in risks for preterm birth, stillbirth, or small-for-gestational-age birth weight among vaccinated patients, there was a statistically significant increase in the risk of hypertensive disorders of pregnancy. Overall, the study suggests a largely favorable safety profile for the RSVpreF vaccine in pregnant individuals.

Reconciling the Literature on Sex-Based Disparities in Reimbursement

Jun 18, 2026

The authors investigate the persistent sex-based disparities in surgical reimbursement, particularly in gynecologic care, and seek to understand their underlying causes. They conclude that significant payment disparities exist at the work relative value unit (RVU) level, which contribute to unequal healthcare resource allocation and the systemic devaluation of female patients. The authors advocate for comprehensive reforms to promote equity in reimbursement practices rather than limited adjustments to specific procedural codes.

High-Dose Oxytocin Protocol Implementation and Postpartum Hemorrhage

Jun 18, 2026

The authors aimed to evaluate the impact of a high-dose oxytocin protocol on the incidence of postpartum hemorrhage (PPH) compared to a standard-dose protocol during the third stage of labor. Their study found that the high-dose protocol significantly reduced PPH rates and median blood loss, particularly among patients with vaginal births, suggesting that this protocol could be beneficial for implementation in other healthcare settings.

The Effects of Climate Change on Obstetric and Gynecologic Health

Jun 18, 2026

The authors investigate how climate change negatively impacts obstetric and gynecologic health, highlighting its association with adverse outcomes such as preterm birth and stillbirth, particularly among marginalized groups. They emphasize the need for obstetrician-gynecologists to educate themselves and their communities about these risks and advocate for the integration of climate change education into medical training and patient counseling.

The Role of Molecular Characterization in Precision Medicine in Endometriosis

Jun 18, 2026

The authors investigate how molecular characterization can enhance precision medicine for endometriosis, a condition that affects many women but is often misdiagnosed and poorly treated. They highlight the need for larger, diverse studies that link genetic profiles to disease symptoms and progression, aiming to develop targeted therapies and improve diagnostic timelines. Ultimately, the goal is to create personalized treatment plans based on the unique molecular characteristics of each patient's endometriosis.

Female Orgasmic Disorder: Current Understanding and Clinical Management

Jun 18, 2026

The authors aim to enhance understanding and clinical management of Female Orgasmic Disorder (FOD), a condition affecting 10-28% of women characterized by persistent difficulty or absence of orgasm. They discuss the complex interplay of neurobiological, hormonal, and psychosocial factors contributing to FOD, the importance of comprehensive biopsychosocial assessments for diagnosis, and the lack of FDA-approved pharmacologic treatments while highlighting the need for individualized management strategies. The review also emphasizes future research directions to improve diagnostic tools and clinical education regarding female sexual health.

Patient-Specific Pessaries After Suboptimal Outcomes With Standard Pessary Use

Jun 18, 2026

The authors aimed to evaluate the effectiveness of patient-specific pessaries for individuals with prior unsuccessful experiences using standard pessaries for pelvic organ prolapse. Their retrospective study found that 77% of patients achieved initial fitting success, with 63.7% continuing to use the device after a home trial, indicating that individualized pessaries may be a viable nonsurgical treatment option for this population.

Comprehensive Analysis and Prognostic Modeling of Epithelioid Trophoblastic Tumor

Jun 18, 2026

The authors aimed to evaluate clinicopathologic factors influencing progression-free survival in patients with epithelioid trophoblastic tumor and to develop validated prognostic models. By analyzing data from 207 patients, they identified key prognostic factors and created two nomograms that demonstrated good predictive performance, particularly the clinicopathologic model. Their findings suggest that these models can aid in personalized risk assessment for affected patients.

Oral and Vaginal Probiotics and Pregnancy Outcomes in Women With Infertility: A Systematic Review and Meta-analysis

Jun 18, 2026

The authors aimed to investigate the impact of oral and vaginal probiotic use on pregnancy outcomes in women experiencing infertility. Their systematic review and meta-analysis of 16 studies revealed that oral probiotics were linked to increased biochemical and clinical pregnancy rates, as well as higher live-birth rates, while vaginal probiotics were associated with a reduced risk of miscarriage. However, the overall quality of the evidence was deemed low to very low.

Hantavirus and Pregnancy: What Obstetricians Need to Know

Jun 16, 2026

The authors aim to inform obstetricians about the implications of hantavirus infection during pregnancy, particularly in light of recent severe cases linked to Andes hantavirus (ANDV). They review existing literature on hantavirus infections, noting the absence of documented cases in pregnant individuals, while emphasizing the importance of recognizing symptoms, providing supportive care, and implementing preventive measures against rodent exposure. The findings highlight the need for heightened awareness and preparedness among clinicians regarding hantavirus in pregnant patients.